Acta Dermato Venereologica · 2015 · 67 citations · 20 references
Life SciencesDermatologyImmunologyAllergyHypersensitivityImmunotherapyAllergen ImmunotherapyAllergic ConditionsAllergic DiseaseAtopic DermatitisImmunoglobulin FunctionType I HypersensitivityAtopic Dermatitis PathogenesisAtopic Dermatitis TreatmentClinical SymptomsIge-mediated HypersensitivityIge-mediated MechanismsImmunoglobulin E (Ige)Immunoglobulin E-mediated ResponsesOmalizumab Therapy
Patients with atopic dermatitis (AD) tend to have greatly elevated levels of serum immunoglobulin E (IgE). However, the role of IgE in the pathogenesis of AD is debated. This investigator-initiated open-label pilot study evaluates an anti-IgE-treatment approach by combining extracorporeal immunoadsorption and anti-IgE antibody omalizumab in 10 patients with severe, therapy-refractory AD. IgE levels decreased after immunoadsorption and decreased continuously in all patients during anti-IgE therapy. The reverse trend was observed during 6 months follow-up without treatment. In parallel with these observations, an improvement in AD was observed during the treatment period, with aggravation during follow-up. Further research is needed, based on the principle of reducing IgE levels in order to improve clinical symptoms, using a combination anti-IgE treatment approach, adjusted according to IgE levels.
20
Severity Scoring of Atopic Dermatitis: The SCORAD Index
Dermatology · 2009 · 2.3K citations
Medicine, Dermatology, Pathology +16
Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
Marcus Maurer, Karin Rosén, Hsin-Ju Hsieh et al. · New England Journal of Medicine · 2013 · 1.1K citations · Full text
Takashi Kakinuma, Koichiro Nakamura, Motoshi Wakugawa et al. · Journal of Allergy and Clinical Immunology · 2001 · 573 citations · Full text
Medicine, Dermatology, Immunology +17